Bronchiolitis obliterans postallogeneic stem cell transplantation: What is new?

被引:2
|
作者
Lemonnier, F. [1 ,2 ]
Dhedin, N. [2 ]
Catherinot, E. [1 ]
Tcherakian, C. [1 ]
Neveu, H. [1 ]
Suarez, F. [3 ]
Becquemin, M. -H. [4 ]
Devillier, P. [5 ,6 ]
Vernant, J. -P. [2 ]
Couderc, L. -J. [1 ,5 ,6 ]
Rivaud, E. [1 ]
机构
[1] Hop Foch, Serv Pneumol, F-92150 Suresnes, France
[2] Grp Hosp Pitie Salpetriere, Serv Hematol Clin, F-75651 Paris 13, France
[3] Hop Necker Enfants Malad, Serv Hematol Clin, F-75743 Paris, France
[4] Grp Hosp Pitie Salpetriere, Serv Explorat Fonct, F-75651 Paris 13, France
[5] Univ Versailles St Quentin En Yvelines, Fac Med Paris Ile de France Ouest, F-78280 Guyancourt, France
[6] Fac Paris Ile de France Ouest, UPRES EA 220, F-92150 Suresnes, France
关键词
Obstructive bronchiolitis; Allogeneic hematopoietic stem cell transplantation; Azythromycin; Imatinib; Lung transplantation; VERSUS-HOST-DISEASE; NONINFECTIOUS PULMONARY COMPLICATIONS; ALLOGENEIC MARROW TRANSPLANTATION; GASTROESOPHAGEAL-REFLUX DISEASE; OBSTRUCTIVE AIRWAYS DISEASE; NECROSIS-FACTOR-ALPHA; AIR-FLOW OBSTRUCTION; BONE-MARROW; LUNG TRANSPLANTATION; PSEUDOMONAS-AERUGINOSA;
D O I
10.1016/j.pneumo.2011.06.003
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Bronchiolitis obliterans (BO) is a severe complication of hematopoietic stem cell transplantation (HSCT). It is considered as a respiratory manifestation of chronic graft-versus-host disease. It is quite similar to the bronchiolitis obliterans after lung transplantation. Classical therapy associates steroids and immunosuppressive drugs, however theses procedure showed a modest efficacy and have an important morbidity. Recent progresses in the physiopathology of BO post-HSCT allow to use new treatments: mTOR inhibitors, immunotherapy, extra-corporeal photochemotherapy, and bronchial anti-inflammatory effects of azithromycin, statins or anti-leucotriens. This review will focus on the use of these new therapies in BO post-HSCT. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:258 / 266
页数:9
相关论文
共 50 条
  • [41] Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
    Kim, Sei Won
    Rhee, Chin Kook
    Kim, Yoo Jin
    Lee, Seok
    Kim, Hee Je
    Lee, Jong Wook
    RESPIRATORY RESEARCH, 2016, 17
  • [42] Acute Bronchodilator Responsiveness in Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation
    Barisione, Giovanni
    Bacigalupo, Andrea
    Crimi, Emanuele
    Brusasco, Vito
    CHEST, 2011, 139 (03) : 633 - 639
  • [43] Multiple Myeloma Complicated With Bronchiolitis Obliterans Syndrome After Allogeneic Haematopoietic Stem Cell Transplantation and Subsequently Underwent Lung Transplantation Successfully: A Case Report
    Huang, Shih-Wei
    Chang, Ko-Wei
    Chen, Wei-Hsun
    Chou, Pin-Li
    Chiu, Chien-Hung
    Liu, Yun-Hen
    Wang, Chih-Wei
    Kao, Hsiao-Wen
    Lin, Tung-Liang
    Leu, Shaw-Woei
    Hu, Han-Chung
    Kao, Kuo-Chin
    RESPIROLOGY CASE REPORTS, 2025, 13 (03):
  • [44] Inert Gas Washout in Bronchiolitis Obliterans Following Hematopoietic Cell Transplantation
    Nyilas, Sylvia
    Baumeler, Luzia
    Tamm, Michael
    Halter, Jorg P.
    Savic, Spasenija
    Korten, Insa
    Meyer, Anja
    Singer, Florian
    Passweg, Jakob R.
    Latzin, Philipp
    Stolz, Daiana
    CHEST, 2018, 154 (01) : 157 - 168
  • [45] Living-donor lobar lung transplantation for broncho-bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: Does bronchiolitis obliterans recur in transplanted lungs?
    Okumura, Hirokazu
    Ohtake, Shigeki
    Ontachi, Yasuo
    Ozaki, Jun
    Shimadoi, Shigeru
    Waseda, Yuko
    Kondo, Yukio
    Yamazaki, Hirohito
    Takami, Akiyoshi
    Yasui, Masahide
    Date, Hiroshi
    Nakao, Shinji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 86 (04) : 369 - 373
  • [46] Living-Donor Lobar Lung Transplantation for Broncho-Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation: Does Bronchiolitis Obliterans Recur in Transplanted Lungs?
    Hirokazu Okumura
    Shigeki Ohtake
    Yasuo Ontachi
    Jun Ozaki
    Shigeru Shimadoi
    Yuko Waseda
    Yukio Kondo
    Hirohito Yamazaki
    Akiyoshi Takami
    Masahide Yasui
    Hiroshi Date
    Shinji Nakao
    International Journal of Hematology, 2007, 86 : 369 - 373
  • [47] Time to Rethink Bronchiolitis Obliterans Syndrome Following Lung or Hematopoietic Cell Transplantation in Pediatric Patients
    Jaing, Tang-Her
    Wang, Yi-Lun
    Chiu, Chia-Chi
    CANCERS, 2024, 16 (21)
  • [48] Radiological Improvement of Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation in a Patient Treated with Ruxolitinib
    Gorospe Sarasua, Luis
    Chinea-Rodriguez, Anabelle
    Almonacid-Sanchez, Carlos
    Alejandro Almeida-Arostegui, Nicolas
    ARCHIVOS DE BRONCONEUMOLOGIA, 2018, 54 (12): : 640 - 642
  • [49] Prevalence, Risk Factors, and Outcomes of Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation
    Bertelli, Luca
    Cazzato, Salvatore
    Belotti, Tamara
    Prete, Arcangelo
    Ricci, Giampaolo
    Pession, Andrea
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2017, 30 (02) : 113 - 115
  • [50] Lung Histology Predicts Outcome of Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation
    Holbro, Andreas
    Lehmann, Thomas
    Girsberger, Sabine
    Stern, Martin
    Gambazzi, Franco
    Lardinois, Didier
    Heim, Dominik
    Passweg, Jakob R.
    Tichelli, Andre
    Bubendorf, Lukas
    Savic, Spasenija
    Hostettler, Katrin
    Grendelmeier, Peter
    Halter, Joerg R.
    Tamm, Michael
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (06) : 973 - 980